Form 424B5 Tenaya Therapeutics,

Go back to Form 424B5 Tenaya Therapeutics,

Tenaya Therapeutics Inc (TNYA) PT Lowered to $2 at Leerink Partners

December 12, 2025 12:18 PM EST

Leerink Partners analyst Mani Foroohar lowered the price target on Tenaya Therapeutics Inc (NASDAQ: TNYA) to $2.00 (from $3.00) while maintaining a Outperform rating.

... More